Ben Younes-Chennoufi A, Meininger V, Léger J M, Bouche P, Jauberteau M O, Baumann N
INSERM Unit 134 Cellular Molecular and Clinical Neurobiology, Salpetriere Hospital, Paris, France.
Neurochem Int. 1992 Apr;20(3):353-7. doi: 10.1016/0197-0186(92)90049-w.
We report here our studies on IgM reactivity towards peripheral nervous system gangliosides, in motor-neuron diseases (MND) without IgM gammopathies, and in peripheral neuropathies with IgM gammopathies. We showed by enzyme linked immunosorbent assay technique, that anti-GM1 IgM antibodies were often present at a low level in normal controls in contrast to anti-GD1b antibodies, which were never detected in control sera. We evidenced that several steps of the ELISA technique were critical such as the nonaddition of detergent in buffer solutions used for dilutions and for washing and the choice of the ELISA plates. We studied 50 cases of motor-neuron diseases, among which 40 typical cases of Amyotrophic Lateral Sclerosis, only a few had high anti-GM1 antibodies levels, which were always confirmed by immunodetection on thin-layer chromatography. These antibodies were generally directed against the oligosaccharide epitope present also in asialoGM1. No correlation has been as yet established in relation to the clinical state of the patients. In a few cases of polyneuropathies associated with IgM gammopathies, antiganglioside antibodies have been reported. We have found anti-GD1b antibodies to be present in a sensory-motor axonal neuropathy; axonal involvement was evidenced by electrophysiological study.
我们在此报告我们对运动神经元疾病(MND)(无IgM型丙种球蛋白病)以及伴有IgM型丙种球蛋白病的周围神经病中IgM对外周神经系统神经节苷脂反应性的研究。我们通过酶联免疫吸附测定技术表明,与抗GD1b抗体相反,抗GM1 IgM抗体在正常对照中常以低水平存在,而抗GD1b抗体在对照血清中从未检测到。我们证明酶联免疫吸附测定技术的几个步骤至关重要,例如在用于稀释和洗涤的缓冲溶液中不添加去污剂以及酶联免疫吸附测定板的选择。我们研究了50例运动神经元疾病病例,其中40例为典型的肌萎缩侧索硬化病例,只有少数病例抗GM1抗体水平较高,这总是通过薄层色谱上的免疫检测得到证实。这些抗体通常针对也存在于去唾液酸GM1中的寡糖表位。尚未发现与患者临床状态相关的相关性。在少数与IgM型丙种球蛋白病相关的多发性神经病病例中,已报告有抗神经节苷脂抗体。我们发现在感觉运动性轴索性神经病中存在抗GD1b抗体;电生理研究证实了轴索受累。